FDA Warns of STAR Ankle Implant Failures medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Dating back to early 2020, the
ARK 3D Printing ETF (CBOE: PRNT) is on a torrid pace, one that’s being facilitated by industrial 3D printing.
PRNT is the first US-listed ETF dedicated to the 3D printing theme. The fund is one of two passively managed products from New York-based Ark Investment Management. ARK believes 3D printing will revolutionize manufacturing by collapsing the time between design and production, reducing costs, and enabling greater design complexity, accuracy, and customization than traditional manufacturing.
Healthcare is one of the most fertile territories for 3D printing. New frontiers are emerging in the arena.
“The FDA has approved its first 3D printed talus metal implant designed to replace the main bone in the ankle joint connecting the leg to the foot. The agency issued a green light to New Jersey-based Additive Orthopaedics under humanitarian use for the treatment of avascular necrosis, a progressive condition that can lead to the death of bone t
3D Printed Metal Ankle Bone is a Step Forward for Orthopedics azom.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from azom.com Daily Mail and Mail on Sunday newspapers.
FDA approves novel 3D-printed talus implant for humanitarian use
Today, the U.S. Food and Drug Administration approved the Patient Specific Talus Spacer 3D-printed talus implant for humanitarian use. The Patient Specific Talus Spacer is the first in the world and first-of-its-kind implant to replace the talus the bone in the ankle joint that connects the leg and the foot for the treatment of avascular necrosis (AVN) of the ankle joint, a serious and progressive condition that causes the death of bone tissue stemming from a lack of blood supply to the area. The implant provides a joint-sparing alternative to other surgical interventions commonly used in late-stage AVN that may disable motion of the ankle joint.
Share this article
Share this article
SILVER SPRING, Md., Feb. 17, 2021 /PRNewswire/ Today, the U.S. Food and Drug Administration approved the Patient Specific Talus Spacer 3D-printed talus implant for humanitarian use. The Patient Specific Talus Spacer is the first in the world and first-of-its-kind implant to replace the talus the bone in the ankle joint that connects the leg and the foot for the treatment of avascular necrosis (AVN) of the ankle joint, a serious and progressive condition that causes the death of bone tissue stemming from a lack of blood supply to the area. The implant provides a joint-sparing alternative to other surgical interventions commonly used in late-stage AVN that may disable motion of the ankle joint.